Bob Kronemyer
Office-based alternative to in-home oral and topical regimen
Application of a topical photoparticle immediately before non-ablative 810 nm diode laser treatment for acne resulted in a statistically significant reduction from baseline in inflammatory acne counts on the back, according to a small feasibility study.
Vollure: The new 18-month filler
According to Allergan, Vollure blends various molecular weights of HA to help achieve an impressive 18 months of duration on average.
Attractive vs. artificial lips
Researchers define a mathematical measurement that determines the threshold for artificial lip augmentation results.
Parents overestimate benefits of antibiotics for acute respiratory infections
Parents often carry misperceptions about the advantages and disadvantages of antibiotic use for pediatric acute respiratory infections, according to an Australian survey in the Annals of Family Medicine.
Lasers in melanoma care
Laser for melanoma in situ (MIS) should generally be reserved for nonsurgical, usually elderly patients. When indicated, MIS may be treated with CO2 laser or with combined Q-switched Nd:YAG and imiquimod. Any atypical-appearing lesion should be biopsied prior to the start of a laser treatment.
Advancements in aesthetic tech
Syneron Candela recently announced the latest updates to their aesthetic technology line of products.
Female lip aesthetic
Researchers are on a quest to determine the ideal female lip aesthetic and its relationship to attractiveness.
PRP for androgenetic alopecia
Is there any real evidence that platelet-rich plasma is effective as an alternative or adjunct to hair transplantation?
Skin cancer advances
Genetic profiling is valuable in both diagnosis and prognosis of skin cancer. Hedgehog inhibitors and (superficial radiation therapy) SRT are strong contenders for treating nonmelanoma skin cancer. Advances in targeted therapies and biologics are part of the new wave of melanoma treatments.
Melanoma surgical management guidelines
All surgical management of melanoma is defined by Breslow thickness. For melanoma less than 1 mm in thickness, typically a SLNB is not required. Future imaging devices may better delineate the extent and depth of the tumor in vivo.


View Results